NewYork–Presbyterian Healthcare System

Newly Approved Lupus Drug Based on Discoveries Made in HSS Lab

Retrieved on: 
Monday, August 2, 2021

Much of the groundwork for the development of this drug was done in laboratories at Hospital for Special Surgery (HSS) in the early 2000s.

Key Points: 
  • Much of the groundwork for the development of this drug was done in laboratories at Hospital for Special Surgery (HSS) in the early 2000s.
  • In lupus, however, this receptor is activated even when no infection is present, causing the immune system to instead attack its host.
  • In the lab, Dr. Crow and her team began studying the blood of people with lupus and comparing it to the blood of healthy individuals.
  • In 2003, Dr. Crow and her HSS team were one of three groups to publish research confirming interferon's pivotal role in lupus.

BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology

Retrieved on: 
Wednesday, July 7, 2021

The PURE EP(tm) is a non-invasive class II device that aims to drive procedural efficiency and efficacy in electrophysiology.

Key Points: 
  • The PURE EP(tm) is a non-invasive class II device that aims to drive procedural efficiency and efficacy in electrophysiology.
  • To date, more than 50 physicians have completed over 1,000 patient cases with the PURE EP(tm) System across twelve clinical sites.
  • The Northeast is one of the three strategic areas that the Company is focused on in the targeted commercial launch phase.
  • BioSigs PURE EP(tm) technology was installed at New York Presbyterian / Weill Cornell Medical Center in New York, NY, one of the nations most comprehensive, integrated healthcare systems and New Yorks top-ranked hospital for 20 years1.

World #1 in Orthopedics Opens HSS Midtown in Manhattan

Retrieved on: 
Monday, June 28, 2021

NEW YORK, June 28, 2021 /PRNewswire/ -- Hospital for Special Surgery (HSS), the academic medical center ranked #1 in the world for Orthopedics according to Newsweek, today opens HSS Midtown at 770 Lexington Avenue in New York City.

Key Points: 
  • NEW YORK, June 28, 2021 /PRNewswire/ -- Hospital for Special Surgery (HSS), the academic medical center ranked #1 in the world for Orthopedics according to Newsweek, today opens HSS Midtown at 770 Lexington Avenue in New York City.
  • "HSS Midtown is designed to overcome many of the reasons why too many people are enduring unnecessary pain and impairment," said HSS Physiatrist-in-Chief Joel M. Press, MD .
  • "HSS has been part of the fabric of midtown Manhattan for more than 100 years, since long before the capabilities of this new location were imaginable," said Louis A. Shapiro, President and CEO of HSS.
  • An entire floor of HSS Midtown is dedicated to Rehabilitation and Performance services, including hand therapy, occupational therapy and performance training.

Weill Cornell Medicine Launches $1.5 Billion "We're Changing Medicine" Campaign with More Than $750 Million in Gifts

Retrieved on: 
Thursday, June 17, 2021

Powering the We're Changing Medicine campaign is $215 million in foundational gifts from several of the institution's most longstanding benefactors.

Key Points: 
  • Powering the We're Changing Medicine campaign is $215 million in foundational gifts from several of the institution's most longstanding benefactors.
  • Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University.
  • "This auspicious milestone will embolden Weill Cornell Medicine's distinguished doctors, researchers and trainees to continue their vital mission to change medicine."
  • "Weill Cornell Medicine exemplifies our mission to develop solutions that meet tomorrow's most pressing challenges, and the We're Changing Medicine campaign will ensure long-lasting advances in science and medicine."

HSS Lerner Children's Pavilion Ranked Best Pediatric Orthopedic Hospital in NY, NJ and CT

Retrieved on: 
Tuesday, June 15, 2021

"HSS is focused solely on providing the safest and most advanced musculoskeletal care," said Bryan T. Kelly, MD , surgeon-in-chief and medical director at HSS.

Key Points: 
  • "HSS is focused solely on providing the safest and most advanced musculoskeletal care," said Bryan T. Kelly, MD , surgeon-in-chief and medical director at HSS.
  • There were more than 44,000 pediatric visits to the HSS Lerner Children's Pavilion to be treated by dedicated surgeons, physicians, anesthesiologists, radiologists, nurses and social workers.
  • HSS is the world's leading academic medical center focused on musculoskeletal health.
  • 4 in rheumatology by U.S. News & World Report (2020-2021), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report "Best Children's Hospitals" list (2021-2022).

Intellihealth Wins AmplifyHer Ventures Investment Competition at Weill Cornell Medicine

Retrieved on: 
Tuesday, May 4, 2021

The competition results were announced at the recent Weill Cornell Medicine Startup Symposium.\nA collaboration between AmplifyHer Ventures and the Weill Cornell Medicine BioVenture eLab, which is part of the Office of BioPharma Alliances and Research Collaborations, the investment competition was designed to highlight the exceptional women innovators at Weill Cornell Medicine and was open to companies across the health care and biopharma sectors that are affiliated with the academic medical institution and have women in key leadership roles.

Key Points: 
  • The competition results were announced at the recent Weill Cornell Medicine Startup Symposium.\nA collaboration between AmplifyHer Ventures and the Weill Cornell Medicine BioVenture eLab, which is part of the Office of BioPharma Alliances and Research Collaborations, the investment competition was designed to highlight the exceptional women innovators at Weill Cornell Medicine and was open to companies across the health care and biopharma sectors that are affiliated with the academic medical institution and have women in key leadership roles.
  • Intellihealth co-founder employee Dr. Katherine Saunders is an assistant professor of clinical medicine at Weill Cornell Medicine and was the first clinical fellow in obesity medicine at its Comprehensive Weight Control Center.\nDr.
  • \xe2\x80\x9cIn assessing the applicants, we immediately recognized that Intellihealth is accurately addressing a real market need.
  • More information and a product demonstration can be found at www.intellihealth.co .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210504005257/en/\n'

Hospital for Special Surgery and Stamford Health Unveil Breakthrough Augmented Reality Technology for Spine Surgery

Retrieved on: 
Tuesday, April 20, 2021

b'STAMFORD, Conn., April 20, 2021 /PRNewswire/ -- HSS Orthopedics at Stamford Health is the first healthcare provider in the region to introduce the most advanced computerized augmented-reality navigation technology for spine surgery.

Key Points: 
  • b'STAMFORD, Conn., April 20, 2021 /PRNewswire/ -- HSS Orthopedics at Stamford Health is the first healthcare provider in the region to introduce the most advanced computerized augmented-reality navigation technology for spine surgery.
  • Spine surgeons equipped with "x-ray vision" have the capability to see through tissue surrounding a patient\'s spine to provide more precise and faster surgeries.
  • Dr. Sandhu performed the surgery in late February at HSS Orthopedics at Stamford Health, using the new AR-based system.\n"I felt immediate relief from my sciatic pain right after surgery.
  • "\nPaul felt assured that HSS Orthopedics at Stamford Health was strictly adhering to all COVID-19 safety protocols, so he had no concerns about any health risks surrounding his spine surgery.

HSS Hand Surgeon Performs First Surgery with FDA-Cleared Wrist Replacement Implant He Designed

Retrieved on: 
Tuesday, April 20, 2021

Last week, he had the first total wrist replacement with KinematX, a new implant co-designed by Scott W. Wolfe, MD , chief emeritus of the Hand and Upper Extremity Service at Hospital for Special Surgery (HSS).

Key Points: 
  • Last week, he had the first total wrist replacement with KinematX, a new implant co-designed by Scott W. Wolfe, MD , chief emeritus of the Hand and Upper Extremity Service at Hospital for Special Surgery (HSS).
  • Seven years ago, he started to investigate treatments and learned about total wrist replacement surgery.
  • But unlike knee and hip replacements, which are common and have excellent outcomes, wrist replacement surgery has not enjoyed the same degree of success.\nMr.
  • "My wrist movement was severely restricted, making it difficult to do anything that required me to bend my wrist.

Michael Enriquez Appointed President, HSS Florida

Retrieved on: 
Friday, April 9, 2021

NEW YORK, April 9, 2021 /PRNewswire/ --Hospital for Special Surgery (HSS) has appointed healthcare leader Michael Enriquez, FACHE as President of HSS Florida.

Key Points: 
  • NEW YORK, April 9, 2021 /PRNewswire/ --Hospital for Special Surgery (HSS) has appointed healthcare leader Michael Enriquez, FACHE as President of HSS Florida.
  • HSS Florida includes a comprehensive outpatient facility in West Palm Beach and offices in Wellington opened within the past 16 months.
  • "Michael is a seasoned health care executive with an intimate knowledge of orthopedics, and weare pleasedthat he will bring hisexpertiseto HSS Florida," said Justin Oppenheimer, HSS Enterprise Chief Operating Officer and Chief Strategy Officer.
  • Mr. Enriquez will direct all operations at HSS Florida, partnering with clinical leadership in Florida, enterprise leadership at the HSS main campus in New York City, and with HSS's partners in the Florida community.

Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Treatment for Patients with COVID Brain Fog

Retrieved on: 
Wednesday, April 7, 2021

Akili Interactive (Akili or Company"), today announced collaborations with Weill Cornell Medicine , NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19 (also known as COVID brain fog).

Key Points: 
  • Akili Interactive (Akili or Company"), today announced collaborations with Weill Cornell Medicine , NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19 (also known as COVID brain fog).
  • We look forward to working with leading researchers at Vanderbilt, Weill Cornell and NewYork-Presbyterian to understand and improve COVID-19-related cognitive deficits.
  • Recent research also shows these cognitive impairments may persist post-hospitalization and commonly occur in post-COVID long haulers or long COVID patients.
  • Half of the study participants will receive the digital treatment for 4 weeks and half will serve as a control group.